Next Generation Sequencing in AML—On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?

Acute myeloid leukemia (AML) is a clonal disease caused by genetic abberations occurring predominantly in the elderly. Next generation sequencing (NGS) analysis has led to a deeper genetic understanding of the pathogenesis and the role of recently discovered genetic precursor lesions (clonal hematop...

Descripción completa

Detalles Bibliográficos
Autores principales: Leisch, Michael, Jansko, Bettina, Zaborsky, Nadja, Greil, Richard, Pleyer, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406956/
https://www.ncbi.nlm.nih.gov/pubmed/30795628
http://dx.doi.org/10.3390/cancers11020252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406956/
https://www.ncbi.nlm.nih.gov/pubmed/30795628
http://dx.doi.org/10.3390/cancers11020252

Ejemplares similares